Indian Pharmaceutical Market
-
{
- All
- News
- Videos
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
- Saturday March 21, 2026
- Health | Indo-Asian News Service
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
- Tuesday February 10, 2026
- Health | Indo-Asian News Service
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
www.ndtv.com
-
India-US Trade Pact To Open $30 Trillion Market For Indian Exporters: Piyush Goyal
- Saturday February 7, 2026
- India News | Press Trust of India
The India-US trade pact will open a $30 trillion market for Indian exporters, especially MSMEs, farmers and fishermen, Commerce and Industry Minister Piyush Goyal said.
-
www.ndtv.com
-
India's Top Export Markets: A Shifting Landscape Explained In Graphics
- Wednesday February 4, 2026
- India News | Reported by Ankita Tiwari, Subham Singh, Raghav Ragi
The United States on Monday slashed tariffs on Indian goods to 18 per cent, down from the previously effective rate of 50 per cent.
-
www.ndtv.com
-
US Revives Drug Origin Debate, Cites Indian Exports
- Friday January 30, 2026
- World News | Indo-Asian News Service
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
www.ndtv.com
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
- Wednesday January 28, 2026
- Health | Written by NDTV Health Desk, Edited by Shreya Goswami
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
New Study Highlights Drug Pricing And Regulation Issues In India
- Wednesday November 12, 2025
- Health | Written by Rupashi Chhabra
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
www.ndtv.com
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
- Friday October 10, 2025
- World News | Edited by NDTV News Desk
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
www.ndtv.com
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
- Friday September 26, 2025
- World News | Edited by Sanstuti Nath
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
www.ndtv.com
-
Trump's 50% Tariffs Unlikely To Significantly Impact India's Growth: Analysts
- Monday August 25, 2025
- India News | Indo-Asian News Service
As the deadline for US secondary tariffs of 25 per cent falls this week over Russian oil purchase, analysts say that a total of 50 per cent tariff is unlikely to significantly impact India's growth due to a robust domestic demand.
-
www.ndtv.com
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
- Friday August 8, 2025
- India News | Asian News International
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
www.ndtv.com
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
- Saturday March 21, 2026
- Health | Indo-Asian News Service
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
www.ndtv.com
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
- Monday March 16, 2026
- Health | Written by Sambhav Kumar
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
www.ndtv.com
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
- Tuesday February 10, 2026
- Health | Indo-Asian News Service
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
www.ndtv.com
-
India-US Trade Pact To Open $30 Trillion Market For Indian Exporters: Piyush Goyal
- Saturday February 7, 2026
- India News | Press Trust of India
The India-US trade pact will open a $30 trillion market for Indian exporters, especially MSMEs, farmers and fishermen, Commerce and Industry Minister Piyush Goyal said.
-
www.ndtv.com
-
India's Top Export Markets: A Shifting Landscape Explained In Graphics
- Wednesday February 4, 2026
- India News | Reported by Ankita Tiwari, Subham Singh, Raghav Ragi
The United States on Monday slashed tariffs on Indian goods to 18 per cent, down from the previously effective rate of 50 per cent.
-
www.ndtv.com
-
US Revives Drug Origin Debate, Cites Indian Exports
- Friday January 30, 2026
- World News | Indo-Asian News Service
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
www.ndtv.com
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
- Wednesday January 28, 2026
- Health | Written by NDTV Health Desk, Edited by Shreya Goswami
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
New Study Highlights Drug Pricing And Regulation Issues In India
- Wednesday November 12, 2025
- Health | Written by Rupashi Chhabra
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
www.ndtv.com
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
- Friday October 10, 2025
- World News | Edited by NDTV News Desk
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
www.ndtv.com
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
- Friday September 26, 2025
- India News | Press Trust of India
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
www.ndtv.com
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
- Friday September 26, 2025
- World News | Edited by Sanstuti Nath
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
www.ndtv.com
-
Trump's 50% Tariffs Unlikely To Significantly Impact India's Growth: Analysts
- Monday August 25, 2025
- India News | Indo-Asian News Service
As the deadline for US secondary tariffs of 25 per cent falls this week over Russian oil purchase, analysts say that a total of 50 per cent tariff is unlikely to significantly impact India's growth due to a robust domestic demand.
-
www.ndtv.com
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
- Friday August 8, 2025
- India News | Asian News International
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
www.ndtv.com